RESPIRATORY INFECTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS, PRIMARY AND SECONDARY AFS BEFORE AND AFTER VACCINATION WITH 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE

被引：0
|
作者：
Koilubaeva, G. [1 ]
Tarasova, G. [2 ]
Belov, B. [2 ]
Bolotbekova, A. [1 ]
Syunbai, K. G. [1 ]
Turatbekova, A. [1 ]
机构：
[1] Rheumatol, 3 Togolok Moldo St, Bishkek, Kyrgyzstan
[2] Rheumatol, Kashirskoye Shosse 34, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Vaccination/immunization;
D O I：
10.1136/annrheumdis-2023-eular.942
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1668
引用
收藏
页码：2070 / 2071
页数：2
相关论文
共 50 条
  • [21] Sex differences in antibody responses to the 23-valent pneumococcal polysaccharide vaccination
    Chiarella, Sergio E.
    Jenkins, Sarah M.
    Park, Miguel A.
    Abraham, Roshini S.
    Joshi, Avni Y.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (04) : 509 - 510
  • [22] TOLERABILITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC VASCULITIS, PRELIMINARY RESULTS
    Tarasova, G.
    Egorova, O.
    Reshetnyak, T.
    Belov, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1435 - 1435
  • [23] Effect of 23-valent pneumococcal polysaccharide vaccine on medical expenses in Japan
    Kazunari Satomura
    Toshitaka Nakahara
    Suketaka Iwanaga
    Megumi Noami
    Keiko Kusaka
    Kazuyoshi Harano
    BMC Health Services Research, 14 (Suppl 2)
  • [24] Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy
    Lu, Ching-Lan
    Chang, Sui-Yuan
    Chuang, Yu-Chung
    Liu, Wen-Chun
    Su, Chin-Ting
    Su, Yi-Ching
    Chang, Shu-Fang
    Hung, Chien-Ching
    VACCINE, 2014, 32 (09) : 1031 - 1035
  • [25] IMMUNOGENICITY AND SAFETY OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH SPONDYLOARTHRITIS
    Muravyeva, N.
    Belov, B.
    Baranova, M.
    Cherkasova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 854 - 855
  • [26] Immunogenicity of A 23-Valent Pneumococcal Polysaccharide Vaccine Among Mexican Children
    Elva Espinosa-Padilla, Sara
    Murata, Chiharu
    Estrada-Parra, Sergio
    Santos-Argumedo, Leopoldo
    Mascarenas, Cesar
    Franco-Paredes, Carlos
    Javier Espinosa-Rosales, Francisco
    ARCHIVES OF MEDICAL RESEARCH, 2012, 43 (05) : 402 - 405
  • [27] Immunogenicity and safety after the third vaccination with the 23-valent pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease
    Ohshima, Nobuharu
    Akeda, Yukihiro
    Nagai, Hideaki
    Oishi, Kazunori
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (09) : 2285 - 2291
  • [28] A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine
    Martinez, JE
    Romero-Steiner, S
    Pilishvili, T
    Barnard, S
    Schinsky, J
    Goldblatt, D
    Carlone, GM
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (04) : 581 - 586
  • [29] EVALUATION OF PNEUMOCOCCAL TITERS AND RESPONSE TO 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN CHILDREN WITH COUGH
    Anthony, K.
    Urrego, F.
    PEDIATRIC PULMONOLOGY, 2014, 49 : S78 - S78
  • [30] Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of Australia
    Michael J. Binks
    Sarah A. Moberley
    Anne Balloch
    Amanda J. Leach
    Sandra Nelson
    Kim M. Hare
    Cate Wilson
    Jane Nelson
    Peter S. Morris
    Robert S. Ware
    Mimi L. K. Tang
    Paul J. Torzillo
    Jonathan R. Carapetis
    Kim Mulholland
    Ross M. Andrews
    Pneumonia, 10 (1)
12345